Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Jadwiga Wedzicha, Donald Banerji, Kenneth Chapman, Jorgen Vestbo, Nicolas Roche, et al.. Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD. New England Journal of Medicine, 2016, 374 (23), pp.2222 - 2234. ⟨10.1056/NEJMoa1516385⟩. ⟨hal-01872709⟩
Journal: New England Journal of Medicine
Date de publication: 09-06-2016
Auteurs:
-
Jadwiga Wedzicha
-
Donald Banerji
-
Kenneth Chapman
-
Jorgen Vestbo
- Nicolas Roche
-
R Timothy Ayers
-
Chau Thach
-
Robert Fogel
-
Francesco Patalano
-
Claus Vogelmeier
-
Arnaud Bourdin
